| Literature DB >> 23002404 |
Jawad A Al-Lawati1, Ibrahim Al-Zakwani, Kadhim Sulaiman, Khalid Al-Habib, Jassim Al Suwaidi, Prashanth Panduranga, Alawi A Alsheikh-Ali, Wael Almahmeed, Husam Al Faleh, Shukri Al Saif, Ahmad Hersi, Nidal Asaad, Ahmed Al-Motarreb, Dimitri P Mikhailidis, Haitham Amin.
Abstract
We used prospective cohort data of patients with acute coronary syndrome (ACS) to compare their management on weekdays/mornings with weekends/nights, and the possible impact of this on 1-month and 1-year mortality. Analyses were evaluated using univariate and multivariate statistics. Of the 4,616 patients admitted to hospitals with ACS, 76% were on weekdays. There were no significant differences in 1-month (odds ratio (OR), 0.88; 95% CI: 0.68-1.14) and 1-year mortality (OR, 0.88; 95% CI: 0.70-1.10), respectively, between weekday and weekend admissions. Similarly, there were no significant differences in 1-month (OR, 0.92; 95% CI: 0.73-1.15) and 1-year mortality (OR, 0.98; 95% CI: 0.80-1.20), respectively, between nights and day admissions. In conclusion, apart from lower utilization of angiography (P < .001) at weekends, there were largely no significant discrepancies in the management and care of patients admitted with ACS on weekdays and during morning hours compared with patients admitted on weekends and night hours, and the overall 30-day and 1-year mortality was similar between both the cohorts.Entities:
Keywords: Acute coronary syndrome; Admission. ; Mortality; Weekday; Weekend
Year: 2012 PMID: 23002404 PMCID: PMC3447162 DOI: 10.2174/1874192401206010106
Source DB: PubMed Journal: Open Cardiovasc Med J ISSN: 1874-1924
Characteristics of Patients Admitted on Weekdays and Weekends with Acute Coronary Syndrome, Oct 2008 to June 2009, Gulf RACE-2
| Characteristic | Weekdays (n = 3,514) | Weekend (n = 1,102) | P |
|---|---|---|---|
| Age±SD, mean, years | 59.6±12.7 | 59.5±12.0 | 0.71 |
| Males (%) | 72.1 | 72.6 | 0.74 |
| Current smokers (%) | 28.4 | 29.5 | 0.49 |
|
| |||
| Diabetes mellitus | 41.6 | 41.7 | 0.95 |
| Hypertension | 50.2 | 49.6 | 0.74 |
| Anaemia | 33.3 | 35.3 | 0.22 |
| Renal diseases | 4.9 | 5.8 | 0.26 |
| Cerebrovascular accident | 5.1 | 6.4 | 0.08 |
| Myocardial infarction | 22.6 | 21.4 | 0.39 |
| Congestive heart failure | 8.5 | 7.5 | 0.30 |
| Valvular heart diseases | 2.0 | 1.4 | 0.27 |
| PCI | 10.5 | 9.8 | 0.49 |
| CABG | 4.9 | 4.9 | 0.94 |
|
| |||
| STEMI | 38.9 | 41.4 | 0.14 |
| Non-STEMI | 31.6 | 32.5 | 0.57 |
| Unstable angina | 29.5 | 26.0 | 0.02 |
|
| |||
| Anterior | 60.2 | 55.8 | |
| Inferior | 37.1 | 40.7 | |
| Lateral | 2.5 | 3.3 | 0.42 |
| Other site | 0.23 | 0.23 | |
|
| |||
| Aspirin | 98.2 | 98.4 | 0.68 |
| Clopidogrel | 71.5 | 71.6 | 0.56 |
| B-blockers | 71.8 | 71.8 | 0.95 |
| ACEI/ARB | 75.7 | 76.9 | 0.45 |
| Statins | 94.0 | 94.4 | 0.67 |
| Heparin | 78.5 | 78.8 | 0.87 |
|
| |||
| Mechanical | 19.3 | 19.9 | 0.69 |
| Arrhythmic | 7.4 | 6.3 | 0.25 |
| Re-infarct | 2.6 | 3.0 | 0.53 |
| Major bleed | 0.7 | 0.7 | 0.96 |
|
| |||
| Angiography | 31.0 | 26.6 | 0.006 |
| PCI | 13.9 | 13.6 | 0.82 |
| CABG | 3.2 | 1.7 | 0.01 |
| Length of stay ±SD, mean, days | 6.4 | 6.1 | 0.24 |
| Door-to-needle ≤30 min (%) (n = 739) | 32.1 | 27.7 | 0.25 |
| Door-to-balloon time ≤90 min (%) (n = 121) | 51.6 | 53.3 | 0.87 |
|
| 10.2 | 9.2 | 0.33 |
| 30-day mortality | 10.2 | 9.2 | 0.33 |
| 1-year mortality | 15.4 | 13.8 | 0.23 |
STEMI, ST-elevation myocardial infarction; ACEI/ARB, Angiotensin converting enzyme inhibitor/angiotensin receptors blockers; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; SD, Standard deviation.
Association between 1-month Mortality and “Weekend Effect” Adjusting for Demographic and Clinical Variables Among Acute Coronary Syndrome Patients in the Middle East
| Characteristic | Odds Ratio | 95% CI | |
|---|---|---|---|
| Weekend | 0.88 | 0.68 | 1.14 |
| Age (yrs) | 1.03 | 1.02 | 1.04 |
| Female sex | 1.06 | 0.82 | 1.37 |
| Current smoking | 1.18 | 0.89 | 1.56 |
| Aspirin | 0.77 | 0.40 | 1.48 |
| Clopidogrel | 1.07 | 0.82 | 1.39 |
| Beta-Blockers | 0.66 | 0.52 | 0.83 |
| ACEI/ARB | 0.56 | 0.44 | 0.71 |
| Statins | 0.72 | 0.49 | 1.06 |
| Heparin | 1.33 | 0.99 | 1.79 |
| History of diabetes | 1.05 | 0.83 | 1.34 |
| History of hypertension | 0.70 | 0.54 | 0.89 |
| History of cerebrovascular disease | 1.20 | 0.79 | 1.83 |
| History of congestive heart failure | 0.69 | 0.47 | 1.00 |
| History of valvular heart disease | 1.25 | 0.64 | 2.47 |
| Renal disease | 1.21 | 0.77 | 1.89 |
| Anaemia on admission | 1.28 | 1.02 | 1.61 |
| Previous myocardial infarction | 1.03 | 0.76 | 1.39 |
| Previous PCI | 0.92 | 0.60 | 1.43 |
| Previous CABG | 0.60 | 0.33 | 1.09 |
| Mechanical complications | 6.73 | 5.27 | 8.60 |
| Arrhythmic complications | 1.79 | 1.29 | 2.47 |
| Length of stay (days) | 1.00 | 0.98 | 1.01 |
| In-hospital re-infarct | 1.74 | 1.06 | 2.86 |
| In-hospital major bleeding | 7.08 | 2.99 | 16.76 |
| Angiography | 0.58 | 0.38 | 0.88 |
| PCI | 1.11 | 0.64 | 1.91 |
| CABG | 0.90 | 0.34 | 2.35 |
ACEI/ARB, Angiotensin converting enzyme inhibitor/angiotensin receptors blockers; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft